OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Contact Info
  • 22 Shacham St.
  • PO Box 8324
  • Petach-Tikva 4918002
  • Israel

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Feb 25, 2016
Company Officers/Contacts
Mordechai Bignitz CEO, President
Ziv Turner COO
Shmuel De-Saban CFO
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Mordechai Bignitz Chairman
Company Notes
  • Formerly=Dynamic Applications Corp. until 1-2015
Service Providers
Accounting/Auditing Firm
4100 North Sam Houston Pkwy W
Suite 200-B
Houston, TX, 77086
United States

Legal Counsel
Office of Richard Rubin
40 Wall Street 28th Floor
New York, NY, 10005
United States

Investor Relations Firm
Not Available
OWCP Security Details
Share Structure
Market Value1 $13,134,331 a/o Dec 09, 2016
Authorized Shares 500,000,000 a/o Nov 30, 2016
Outstanding Shares 135,405,474 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 86,515,750 a/o Oct 31, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 250 a/o Oct 31, 2016
Short Selling Data
Short Interest 16,703 (-95.1%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security